Global Dermatomycoses Drug Market Insights, Forecast to 2028

Global Dermatomycoses Drug Market Insights, Forecast to 2028

Table of Contents
1 Study Coverage
1.1 Dermatomycoses Drug Product Introduction
1.2 Market by Type
1.2.1 Global Dermatomycoses Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 BB-2603
1.2.3 Clotrimazole
1.2.4 Dapaconazole
1.2.5 Others
1.3 Market by Application
1.3.1 Global Dermatomycoses Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Dermatomycoses Drug Sales Estimates and Forecasts 2017-2028
2.2 Global Dermatomycoses Drug Revenue Estimates and Forecasts 2017-2028
2.3 Global Dermatomycoses Drug Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Dermatomycoses Drug Sales by Region
2.4.1 Global Dermatomycoses Drug Sales by Region (2017-2022)
2.4.2 Global Sales Dermatomycoses Drug by Region (2023-2028)
2.5 Global Dermatomycoses Drug Revenue by Region
2.5.1 Global Dermatomycoses Drug Revenue by Region (2017-2022)
2.5.2 Global Dermatomycoses Drug Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Dermatomycoses Drug Sales by Manufacturers
3.1.1 Global Top Dermatomycoses Drug Manufacturers by Sales (2017-2022)
3.1.2 Global Dermatomycoses Drug Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Dermatomycoses Drug in 2021
3.2 Global Dermatomycoses Drug Revenue by Manufacturers
3.2.1 Global Dermatomycoses Drug Revenue by Manufacturers (2017-2022)
3.2.2 Global Dermatomycoses Drug Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Dermatomycoses Drug Revenue in 2021
3.3 Global Dermatomycoses Drug Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Dermatomycoses Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Dermatomycoses Drug Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Dermatomycoses Drug Sales by Type
4.1.1 Global Dermatomycoses Drug Historical Sales by Type (2017-2022)
4.1.2 Global Dermatomycoses Drug Forecasted Sales by Type (2023-2028)
4.1.3 Global Dermatomycoses Drug Sales Market Share by Type (2017-2028)
4.2 Global Dermatomycoses Drug Revenue by Type
4.2.1 Global Dermatomycoses Drug Historical Revenue by Type (2017-2022)
4.2.2 Global Dermatomycoses Drug Forecasted Revenue by Type (2023-2028)
4.2.3 Global Dermatomycoses Drug Revenue Market Share by Type (2017-2028)
4.3 Global Dermatomycoses Drug Price by Type
4.3.1 Global Dermatomycoses Drug Price by Type (2017-2022)
4.3.2 Global Dermatomycoses Drug Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Dermatomycoses Drug Sales by Application
5.1.1 Global Dermatomycoses Drug Historical Sales by Application (2017-2022)
5.1.2 Global Dermatomycoses Drug Forecasted Sales by Application (2023-2028)
5.1.3 Global Dermatomycoses Drug Sales Market Share by Application (2017-2028)
5.2 Global Dermatomycoses Drug Revenue by Application
5.2.1 Global Dermatomycoses Drug Historical Revenue by Application (2017-2022)
5.2.2 Global Dermatomycoses Drug Forecasted Revenue by Application (2023-2028)
5.2.3 Global Dermatomycoses Drug Revenue Market Share by Application (2017-2028)
5.3 Global Dermatomycoses Drug Price by Application
5.3.1 Global Dermatomycoses Drug Price by Application (2017-2022)
5.3.2 Global Dermatomycoses Drug Price Forecast by Application (2023-2028)
6 North America
6.1 North America Dermatomycoses Drug Market Size by Type
6.1.1 North America Dermatomycoses Drug Sales by Type (2017-2028)
6.1.2 North America Dermatomycoses Drug Revenue by Type (2017-2028)
6.2 North America Dermatomycoses Drug Market Size by Application
6.2.1 North America Dermatomycoses Drug Sales by Application (2017-2028)
6.2.2 North America Dermatomycoses Drug Revenue by Application (2017-2028)
6.3 North America Dermatomycoses Drug Market Size by Country
6.3.1 North America Dermatomycoses Drug Sales by Country (2017-2028)
6.3.2 North America Dermatomycoses Drug Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Dermatomycoses Drug Market Size by Type
7.1.1 Europe Dermatomycoses Drug Sales by Type (2017-2028)
7.1.2 Europe Dermatomycoses Drug Revenue by Type (2017-2028)
7.2 Europe Dermatomycoses Drug Market Size by Application
7.2.1 Europe Dermatomycoses Drug Sales by Application (2017-2028)
7.2.2 Europe Dermatomycoses Drug Revenue by Application (2017-2028)
7.3 Europe Dermatomycoses Drug Market Size by Country
7.3.1 Europe Dermatomycoses Drug Sales by Country (2017-2028)
7.3.2 Europe Dermatomycoses Drug Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Dermatomycoses Drug Market Size by Type
8.1.1 Asia Pacific Dermatomycoses Drug Sales by Type (2017-2028)
8.1.2 Asia Pacific Dermatomycoses Drug Revenue by Type (2017-2028)
8.2 Asia Pacific Dermatomycoses Drug Market Size by Application
8.2.1 Asia Pacific Dermatomycoses Drug Sales by Application (2017-2028)
8.2.2 Asia Pacific Dermatomycoses Drug Revenue by Application (2017-2028)
8.3 Asia Pacific Dermatomycoses Drug Market Size by Region
8.3.1 Asia Pacific Dermatomycoses Drug Sales by Region (2017-2028)
8.3.2 Asia Pacific Dermatomycoses Drug Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Dermatomycoses Drug Market Size by Type
9.1.1 Latin America Dermatomycoses Drug Sales by Type (2017-2028)
9.1.2 Latin America Dermatomycoses Drug Revenue by Type (2017-2028)
9.2 Latin America Dermatomycoses Drug Market Size by Application
9.2.1 Latin America Dermatomycoses Drug Sales by Application (2017-2028)
9.2.2 Latin America Dermatomycoses Drug Revenue by Application (2017-2028)
9.3 Latin America Dermatomycoses Drug Market Size by Country
9.3.1 Latin America Dermatomycoses Drug Sales by Country (2017-2028)
9.3.2 Latin America Dermatomycoses Drug Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Dermatomycoses Drug Market Size by Type
10.1.1 Middle East and Africa Dermatomycoses Drug Sales by Type (2017-2028)
10.1.2 Middle East and Africa Dermatomycoses Drug Revenue by Type (2017-2028)
10.2 Middle East and Africa Dermatomycoses Drug Market Size by Application
10.2.1 Middle East and Africa Dermatomycoses Drug Sales by Application (2017-2028)
10.2.2 Middle East and Africa Dermatomycoses Drug Revenue by Application (2017-2028)
10.3 Middle East and Africa Dermatomycoses Drug Market Size by Country
10.3.1 Middle East and Africa Dermatomycoses Drug Sales by Country (2017-2028)
10.3.2 Middle East and Africa Dermatomycoses Drug Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Anacor Pharmaceuticals Inc
11.1.1 Anacor Pharmaceuticals Inc Corporation Information
11.1.2 Anacor Pharmaceuticals Inc Overview
11.1.3 Anacor Pharmaceuticals Inc Dermatomycoses Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Anacor Pharmaceuticals Inc Dermatomycoses Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Anacor Pharmaceuticals Inc Recent Developments
11.2 Biolab Farmaceutica Ltda
11.2.1 Biolab Farmaceutica Ltda Corporation Information
11.2.2 Biolab Farmaceutica Ltda Overview
11.2.3 Biolab Farmaceutica Ltda Dermatomycoses Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Biolab Farmaceutica Ltda Dermatomycoses Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Biolab Farmaceutica Ltda Recent Developments
11.3 Blueberry Therapeutics Ltd
11.3.1 Blueberry Therapeutics Ltd Corporation Information
11.3.2 Blueberry Therapeutics Ltd Overview
11.3.3 Blueberry Therapeutics Ltd Dermatomycoses Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Blueberry Therapeutics Ltd Dermatomycoses Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Blueberry Therapeutics Ltd Recent Developments
11.4 Daewoong Pharmaceutical Co Ltd
11.4.1 Daewoong Pharmaceutical Co Ltd Corporation Information
11.4.2 Daewoong Pharmaceutical Co Ltd Overview
11.4.3 Daewoong Pharmaceutical Co Ltd Dermatomycoses Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Daewoong Pharmaceutical Co Ltd Dermatomycoses Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Daewoong Pharmaceutical Co Ltd Recent Developments
11.5 Dermala Inc
11.5.1 Dermala Inc Corporation Information
11.5.2 Dermala Inc Overview
11.5.3 Dermala Inc Dermatomycoses Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Dermala Inc Dermatomycoses Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Dermala Inc Recent Developments
11.6 Helix BioMedix Inc
11.6.1 Helix BioMedix Inc Corporation Information
11.6.2 Helix BioMedix Inc Overview
11.6.3 Helix BioMedix Inc Dermatomycoses Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Helix BioMedix Inc Dermatomycoses Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Helix BioMedix Inc Recent Developments
11.7 Novan Inc
11.7.1 Novan Inc Corporation Information
11.7.2 Novan Inc Overview
11.7.3 Novan Inc Dermatomycoses Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Novan Inc Dermatomycoses Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Novan Inc Recent Developments
11.8 Sol-Gel Technologies Ltd
11.8.1 Sol-Gel Technologies Ltd Corporation Information
11.8.2 Sol-Gel Technologies Ltd Overview
11.8.3 Sol-Gel Technologies Ltd Dermatomycoses Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Sol-Gel Technologies Ltd Dermatomycoses Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Sol-Gel Technologies Ltd Recent Developments
11.9 TGV-Laboratories
11.9.1 TGV-Laboratories Corporation Information
11.9.2 TGV-Laboratories Overview
11.9.3 TGV-Laboratories Dermatomycoses Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 TGV-Laboratories Dermatomycoses Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 TGV-Laboratories Recent Developments
11.10 Viamet Pharmaceuticals Inc
11.10.1 Viamet Pharmaceuticals Inc Corporation Information
11.10.2 Viamet Pharmaceuticals Inc Overview
11.10.3 Viamet Pharmaceuticals Inc Dermatomycoses Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Viamet Pharmaceuticals Inc Dermatomycoses Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Viamet Pharmaceuticals Inc Recent Developments
11.11 Vyome Biosciences Pvt Ltd
11.11.1 Vyome Biosciences Pvt Ltd Corporation Information
11.11.2 Vyome Biosciences Pvt Ltd Overview
11.11.3 Vyome Biosciences Pvt Ltd Dermatomycoses Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Vyome Biosciences Pvt Ltd Dermatomycoses Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Vyome Biosciences Pvt Ltd Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Dermatomycoses Drug Industry Chain Analysis
12.2 Dermatomycoses Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Dermatomycoses Drug Production Mode & Process
12.4 Dermatomycoses Drug Sales and Marketing
12.4.1 Dermatomycoses Drug Sales Channels
12.4.2 Dermatomycoses Drug Distributors
12.5 Dermatomycoses Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Dermatomycoses Drug Industry Trends
13.2 Dermatomycoses Drug Market Drivers
13.3 Dermatomycoses Drug Market Challenges
13.4 Dermatomycoses Drug Market Restraints
14 Key Findings in The Global Dermatomycoses Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Dermatomycoses Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of BB-2603
Table 3. Major Manufacturers of Clotrimazole
Table 4. Major Manufacturers of Dapaconazole
Table 5. Major Manufacturers of Others
Table 6. Global Dermatomycoses Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Dermatomycoses Drug Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Dermatomycoses Drug Sales by Region (2017-2022) & (K Units)
Table 9. Global Dermatomycoses Drug Sales Market Share by Region (2017-2022)
Table 10. Global Dermatomycoses Drug Sales by Region (2023-2028) & (K Units)
Table 11. Global Dermatomycoses Drug Sales Market Share by Region (2023-2028)
Table 12. Global Dermatomycoses Drug Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Dermatomycoses Drug Revenue Market Share by Region (2017-2022)
Table 14. Global Dermatomycoses Drug Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Dermatomycoses Drug Revenue Market Share by Region (2023-2028)
Table 16. Global Dermatomycoses Drug Sales by Manufacturers (2017-2022) & (K Units)
Table 17. Global Dermatomycoses Drug Sales Share by Manufacturers (2017-2022)
Table 18. Global Dermatomycoses Drug Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Dermatomycoses Drug Revenue Share by Manufacturers (2017-2022)
Table 20. Dermatomycoses Drug Price by Manufacturers (2017-2022) &(USD/Unit)
Table 21. Global Dermatomycoses Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Dermatomycoses Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dermatomycoses Drug as of 2021)
Table 23. Dermatomycoses Drug Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Dermatomycoses Drug Product Offered
Table 25. Date of Manufacturers Enter into Dermatomycoses Drug Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Dermatomycoses Drug Sales by Type (2017-2022) & (K Units)
Table 28. Global Dermatomycoses Drug Sales by Type (2023-2028) & (K Units)
Table 29. Global Dermatomycoses Drug Sales Share by Type (2017-2022)
Table 30. Global Dermatomycoses Drug Sales Share by Type (2023-2028)
Table 31. Global Dermatomycoses Drug Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Dermatomycoses Drug Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global Dermatomycoses Drug Revenue Share by Type (2017-2022)
Table 34. Global Dermatomycoses Drug Revenue Share by Type (2023-2028)
Table 35. Dermatomycoses Drug Price by Type (2017-2022) & (USD/Unit)
Table 36. Global Dermatomycoses Drug Price Forecast by Type (2023-2028) & (USD/Unit)
Table 37. Global Dermatomycoses Drug Sales by Application (2017-2022) & (K Units)
Table 38. Global Dermatomycoses Drug Sales by Application (2023-2028) & (K Units)
Table 39. Global Dermatomycoses Drug Sales Share by Application (2017-2022)
Table 40. Global Dermatomycoses Drug Sales Share by Application (2023-2028)
Table 41. Global Dermatomycoses Drug Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global Dermatomycoses Drug Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global Dermatomycoses Drug Revenue Share by Application (2017-2022)
Table 44. Global Dermatomycoses Drug Revenue Share by Application (2023-2028)
Table 45. Dermatomycoses Drug Price by Application (2017-2022) & (USD/Unit)
Table 46. Global Dermatomycoses Drug Price Forecast by Application (2023-2028) & (USD/Unit)
Table 47. North America Dermatomycoses Drug Sales by Type (2017-2022) & (K Units)
Table 48. North America Dermatomycoses Drug Sales by Type (2023-2028) & (K Units)
Table 49. North America Dermatomycoses Drug Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Dermatomycoses Drug Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America Dermatomycoses Drug Sales by Application (2017-2022) & (K Units)
Table 52. North America Dermatomycoses Drug Sales by Application (2023-2028) & (K Units)
Table 53. North America Dermatomycoses Drug Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America Dermatomycoses Drug Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America Dermatomycoses Drug Sales by Country (2017-2022) & (K Units)
Table 56. North America Dermatomycoses Drug Sales by Country (2023-2028) & (K Units)
Table 57. North America Dermatomycoses Drug Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Dermatomycoses Drug Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Dermatomycoses Drug Sales by Type (2017-2022) & (K Units)
Table 60. Europe Dermatomycoses Drug Sales by Type (2023-2028) & (K Units)
Table 61. Europe Dermatomycoses Drug Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Dermatomycoses Drug Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe Dermatomycoses Drug Sales by Application (2017-2022) & (K Units)
Table 64. Europe Dermatomycoses Drug Sales by Application (2023-2028) & (K Units)
Table 65. Europe Dermatomycoses Drug Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe Dermatomycoses Drug Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe Dermatomycoses Drug Sales by Country (2017-2022) & (K Units)
Table 68. Europe Dermatomycoses Drug Sales by Country (2023-2028) & (K Units)
Table 69. Europe Dermatomycoses Drug Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Dermatomycoses Drug Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Dermatomycoses Drug Sales by Type (2017-2022) & (K Units)
Table 72. Asia Pacific Dermatomycoses Drug Sales by Type (2023-2028) & (K Units)
Table 73. Asia Pacific Dermatomycoses Drug Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Dermatomycoses Drug Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific Dermatomycoses Drug Sales by Application (2017-2022) & (K Units)
Table 76. Asia Pacific Dermatomycoses Drug Sales by Application (2023-2028) & (K Units)
Table 77. Asia Pacific Dermatomycoses Drug Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific Dermatomycoses Drug Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific Dermatomycoses Drug Sales by Region (2017-2022) & (K Units)
Table 80. Asia Pacific Dermatomycoses Drug Sales by Region (2023-2028) & (K Units)
Table 81. Asia Pacific Dermatomycoses Drug Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Dermatomycoses Drug Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Dermatomycoses Drug Sales by Type (2017-2022) & (K Units)
Table 84. Latin America Dermatomycoses Drug Sales by Type (2023-2028) & (K Units)
Table 85. Latin America Dermatomycoses Drug Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Dermatomycoses Drug Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America Dermatomycoses Drug Sales by Application (2017-2022) & (K Units)
Table 88. Latin America Dermatomycoses Drug Sales by Application (2023-2028) & (K Units)
Table 89. Latin America Dermatomycoses Drug Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America Dermatomycoses Drug Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America Dermatomycoses Drug Sales by Country (2017-2022) & (K Units)
Table 92. Latin America Dermatomycoses Drug Sales by Country (2023-2028) & (K Units)
Table 93. Latin America Dermatomycoses Drug Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Dermatomycoses Drug Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Dermatomycoses Drug Sales by Type (2017-2022) & (K Units)
Table 96. Middle East and Africa Dermatomycoses Drug Sales by Type (2023-2028) & (K Units)
Table 97. Middle East and Africa Dermatomycoses Drug Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Dermatomycoses Drug Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Dermatomycoses Drug Sales by Application (2017-2022) & (K Units)
Table 100. Middle East and Africa Dermatomycoses Drug Sales by Application (2023-2028) & (K Units)
Table 101. Middle East and Africa Dermatomycoses Drug Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Dermatomycoses Drug Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Dermatomycoses Drug Sales by Country (2017-2022) & (K Units)
Table 104. Middle East and Africa Dermatomycoses Drug Sales by Country (2023-2028) & (K Units)
Table 105. Middle East and Africa Dermatomycoses Drug Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Dermatomycoses Drug Revenue by Country (2023-2028) & (US$ Million)
Table 107. Anacor Pharmaceuticals Inc Corporation Information
Table 108. Anacor Pharmaceuticals Inc Description and Major Businesses
Table 109. Anacor Pharmaceuticals Inc Dermatomycoses Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 110. Anacor Pharmaceuticals Inc Dermatomycoses Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Anacor Pharmaceuticals Inc Recent Developments
Table 112. Biolab Farmaceutica Ltda Corporation Information
Table 113. Biolab Farmaceutica Ltda Description and Major Businesses
Table 114. Biolab Farmaceutica Ltda Dermatomycoses Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 115. Biolab Farmaceutica Ltda Dermatomycoses Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Biolab Farmaceutica Ltda Recent Developments
Table 117. Blueberry Therapeutics Ltd Corporation Information
Table 118. Blueberry Therapeutics Ltd Description and Major Businesses
Table 119. Blueberry Therapeutics Ltd Dermatomycoses Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 120. Blueberry Therapeutics Ltd Dermatomycoses Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Blueberry Therapeutics Ltd Recent Developments
Table 122. Daewoong Pharmaceutical Co Ltd Corporation Information
Table 123. Daewoong Pharmaceutical Co Ltd Description and Major Businesses
Table 124. Daewoong Pharmaceutical Co Ltd Dermatomycoses Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 125. Daewoong Pharmaceutical Co Ltd Dermatomycoses Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Daewoong Pharmaceutical Co Ltd Recent Developments
Table 127. Dermala Inc Corporation Information
Table 128. Dermala Inc Description and Major Businesses
Table 129. Dermala Inc Dermatomycoses Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 130. Dermala Inc Dermatomycoses Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Dermala Inc Recent Developments
Table 132. Helix BioMedix Inc Corporation Information
Table 133. Helix BioMedix Inc Description and Major Businesses
Table 134. Helix BioMedix Inc Dermatomycoses Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 135. Helix BioMedix Inc Dermatomycoses Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Helix BioMedix Inc Recent Developments
Table 137. Novan Inc Corporation Information
Table 138. Novan Inc Description and Major Businesses
Table 139. Novan Inc Dermatomycoses Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 140. Novan Inc Dermatomycoses Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Novan Inc Recent Developments
Table 142. Sol-Gel Technologies Ltd Corporation Information
Table 143. Sol-Gel Technologies Ltd Description and Major Businesses
Table 144. Sol-Gel Technologies Ltd Dermatomycoses Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 145. Sol-Gel Technologies Ltd Dermatomycoses Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Sol-Gel Technologies Ltd Recent Developments
Table 147. TGV-Laboratories Corporation Information
Table 148. TGV-Laboratories Description and Major Businesses
Table 149. TGV-Laboratories Dermatomycoses Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 150. TGV-Laboratories Dermatomycoses Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. TGV-Laboratories Recent Developments
Table 152. Viamet Pharmaceuticals Inc Corporation Information
Table 153. Viamet Pharmaceuticals Inc Description and Major Businesses
Table 154. Viamet Pharmaceuticals Inc Dermatomycoses Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 155. Viamet Pharmaceuticals Inc Dermatomycoses Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Viamet Pharmaceuticals Inc Recent Developments
Table 157. Vyome Biosciences Pvt Ltd Corporation Information
Table 158. Vyome Biosciences Pvt Ltd Description and Major Businesses
Table 159. Vyome Biosciences Pvt Ltd Dermatomycoses Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 160. Vyome Biosciences Pvt Ltd Dermatomycoses Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Vyome Biosciences Pvt Ltd Recent Developments
Table 162. Key Raw Materials Lists
Table 163. Raw Materials Key Suppliers Lists
Table 164. Dermatomycoses Drug Distributors List
Table 165. Dermatomycoses Drug Customers List
Table 166. Dermatomycoses Drug Market Trends
Table 167. Dermatomycoses Drug Market Drivers
Table 168. Dermatomycoses Drug Market Challenges
Table 169. Dermatomycoses Drug Market Restraints
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources
List of Figures
Figure 1. Dermatomycoses Drug Product Picture
Figure 3. Global Dermatomycoses Drug Market Share by Type in 2021 & 2028
Figure 3. BB-2603 Product Picture
Figure 4. Clotrimazole Product Picture
Figure 5. Dapaconazole Product Picture
Figure 6. Others Product Picture
Figure 7. Global Dermatomycoses Drug Market Share by Application in 2021 & 2028
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Others
Figure 11. Dermatomycoses Drug Report Years Considered
Figure 12. Global Dermatomycoses Drug Sales 2017-2028 (K Units)
Figure 13. Global Dermatomycoses Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Dermatomycoses Drug Revenue 2017-2028 (US$ Million)
Figure 15. Global Dermatomycoses Drug Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 16. Global Dermatomycoses Drug Sales Market Share by Region (2017-2022)
Figure 17. Global Dermatomycoses Drug Sales Market Share by Region (2023-2028)
Figure 18. North America Dermatomycoses Drug Sales YoY (2017-2028) & (K Units)
Figure 19. North America Dermatomycoses Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Europe Dermatomycoses Drug Sales YoY (2017-2028) & (K Units)
Figure 21. Europe Dermatomycoses Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Asia-Pacific Dermatomycoses Drug Sales YoY (2017-2028) & (K Units)
Figure 23. Asia-Pacific Dermatomycoses Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Latin America Dermatomycoses Drug Sales YoY (2017-2028) & (K Units)
Figure 25. Latin America Dermatomycoses Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Middle East & Africa Dermatomycoses Drug Sales YoY (2017-2028) & (K Units)
Figure 27. Middle East & Africa Dermatomycoses Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 28. The Dermatomycoses Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 29. The Top 5 and 10 Largest Manufacturers of Dermatomycoses Drug in the World: Market Share by Dermatomycoses Drug Revenue in 2021
Figure 30. Global Dermatomycoses Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 31. Global Dermatomycoses Drug Sales Market Share by Type (2017-2028)
Figure 32. Global Dermatomycoses Drug Revenue Market Share by Type (2017-2028)
Figure 33. Global Dermatomycoses Drug Sales Market Share by Application (2017-2028)
Figure 34. Global Dermatomycoses Drug Revenue Market Share by Application (2017-2028)
Figure 35. North America Dermatomycoses Drug Sales Market Share by Type (2017-2028)
Figure 36. North America Dermatomycoses Drug Revenue Market Share by Type (2017-2028)
Figure 37. North America Dermatomycoses Drug Sales Market Share by Application (2017-2028)
Figure 38. North America Dermatomycoses Drug Revenue Market Share by Application (2017-2028)
Figure 39. North America Dermatomycoses Drug Sales Share by Country (2017-2028)
Figure 40. North America Dermatomycoses Drug Revenue Share by Country (2017-2028)
Figure 41. U.S. Dermatomycoses Drug Revenue (2017-2028) & (US$ Million)
Figure 42. Canada Dermatomycoses Drug Revenue (2017-2028) & (US$ Million)
Figure 43. Europe Dermatomycoses Drug Sales Market Share by Type (2017-2028)
Figure 44. Europe Dermatomycoses Drug Revenue Market Share by Type (2017-2028)
Figure 45. Europe Dermatomycoses Drug Sales Market Share by Application (2017-2028)
Figure 46. Europe Dermatomycoses Drug Revenue Market Share by Application (2017-2028)
Figure 47. Europe Dermatomycoses Drug Sales Share by Country (2017-2028)
Figure 48. Europe Dermatomycoses Drug Revenue Share by Country (2017-2028)
Figure 49. Germany

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs